AvalehtMEHCQ • OTCMKTS
add
23andMe Holding Co
Viimane sulgemishind
4,24 $
Tänane vahemik
4,05 $ - 4,39 $
Aasta vahemik
0,47 $ - 10,81 $
Turuväärtus
117,60 mln USD
Keskmine maht
575,71 tuh
P/E suhe
-
Dividendimäär
-
Põhibörs
OTCMKTS
Börsiuudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
(USD) | märts 2025info | Y/Y muutus |
---|---|---|
Käive | 45,15 mln | −29,49% |
Põhitegevusega seonduv kulu | 65,51 mln | −34,62% |
Puhastulu | −99,35 mln | 52,43% |
Puhaskasumimarginaal | −220,04 | 32,54% |
Puhaskasum aktsia kohta | — | — |
EBITDA | −45,06 mln | 35,08% |
Tõhus maksumäär | 0,00% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
(USD) | märts 2025info | Y/Y muutus |
---|---|---|
Sularaha ja lühiajalised investeeringud | 38,25 mln | −82,33% |
Kogu vara | 159,89 mln | −59,54% |
Kõik kohustused | 186,64 mln | −9,68% |
Kogu omakapital | −26,74 mln | — |
Emiteeritud aktsiate arv | 27,54 mln | — |
Hinna ja väärtuse suhe P/B | −4,37 | — |
Varade tasuvus | −54,88% | — |
Kapitali tasuvus | −230,70% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
(USD) | märts 2025info | Y/Y muutus |
---|---|---|
Puhastulu | −99,35 mln | 52,43% |
Põhitegevuse rahakäive | −40,73 mln | −57,97% |
Investeeringute raha | −734,00 tuh | 65,80% |
Finantseerimise raha | −529,00 tuh | −126,45% |
Raha ja raha ekvivalentide muutus | −41,99 mln | −61,95% |
Tasuta rahavoog | −82,91 mln | −285,64% |
Teave
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Asutatud
apr 2006
Veebisait
Töötajate arv
261